| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBRC.2010.01.119 |
| P698 | PubMed publication ID | 20123087 |
| P50 | author | Stefan Angielski | Q9344848 |
| Dorota Rogacka | Q56975406 | ||
| Agnieszka Piwkowska | Q56975420 | ||
| P2093 | author name string | Maciej Jankowski | |
| Jan Kazimierz Stepiński | |||
| Marek Henryk Dominiczak | |||
| P2860 | cites work | Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. | Q41084039 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metformin | Q19484 |
| P304 | page(s) | 268-273 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Metformin induces suppression of NAD(P)H oxidase activity in podocytes | |
| P478 | volume | 393 |
| Q36114705 | A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells |
| Q37062840 | AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model |
| Q24610297 | AMP-activated protein kinase, stress responses and cardiovascular diseases |
| Q33689169 | AMPK activation--protean potential for boosting healthspan |
| Q48242829 | Activation of AMP-activated protein kinase by metformin ablates angiotensin II-induced endoplasmic reticulum stress and hypertension in mice in vivo |
| Q52724019 | Acute Kidney Injury and Progression of Diabetic Kidney Disease. |
| Q36735820 | Angiotensin II Modulates p130Cas of Podocytes by the Suppression of AMP-Activated Protein Kinase. |
| Q39328191 | Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling |
| Q34450629 | Antioxidants induce apoptosis of rat ovarian theca-interstitial cells |
| Q27013561 | Cellular and molecular mechanisms of metformin: an overview |
| Q39060497 | Cellular senescence in renal ageing and disease |
| Q34438700 | Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene |
| Q34502046 | Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 rat |
| Q37597721 | Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury |
| Q36466042 | Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytes |
| Q26769787 | Drug Targets for Oxidative Podocyte Injury in Diabetic Nephropathy |
| Q43689094 | Extracellular ATP through P2 receptors activates AMP-activated protein kinase and suppresses superoxide generation in cultured mouse podocytes |
| Q88614072 | Frontline Science: Pathological conditioning of human neutrophils recruited to the airway milieu in cystic fibrosis |
| Q35590438 | Genome protective effect of metformin as revealed by reduced level of constitutive DNA damage signaling |
| Q43810184 | High glucose increases glomerular filtration barrier permeability by activating protein kinase G type Iα subunits in a Nox4-dependent manner. |
| Q46216330 | Hydrogen peroxide induces dimerization of protein kinase G type Iα subunits and increases albumin permeability in cultured rat podocytes. |
| Q36759153 | Hyperglycemia-Mediated Oxidative Stress Increases Pulmonary Vascular Permeability |
| Q35925936 | In adenosine A2B knockouts acute treatment with inorganic nitrate improves glucose disposal, oxidative stress, and AMPK signaling in the liver |
| Q37142481 | Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease |
| Q41481747 | METABOLIC EFFECTS OF TULBAGHIA VIOLACEA HARV. IN A DIABETIC MODEL |
| Q26766259 | Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control |
| Q46594445 | Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activation. |
| Q58728734 | Metabolic Profiles Associated With Metformin Efficacy in Cancer |
| Q41108451 | Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats |
| Q42250805 | Metformin Improves Metabolic Memory in High Fat Diet (HFD)-induced Renal Dysfunction. |
| Q37342614 | Metformin Prevents Renal Stone Formation through an Antioxidant Mechanism In Vitro and In Vivo. |
| Q36447454 | Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice |
| Q51161289 | Metformin ameliorates ovariectomy-induced vascular dysfunction in non-diabetic Wistar rats. |
| Q38737184 | Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions. |
| Q37522894 | Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1. |
| Q91142614 | Metformin prevents vascular damage in hypertension through the AMPK/ER stress pathway |
| Q36640261 | Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro. |
| Q60939760 | Metformin: A Candidate Drug for Renal Diseases |
| Q26853666 | Metformin: Current knowledge |
| Q38954169 | Nephroprotective Effects of Metformin in Diabetic Nephropathy. |
| Q38092960 | Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? |
| Q35664105 | Osmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes. |
| Q36010534 | Protective effects of leukemia inhibitory factor against oxidative stress during high glucose-induced apoptosis in podocytes |
| Q35925959 | Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems |
| Q37351517 | Role of NADPH oxidase-mediated reactive oxygen species in podocyte injury |
| Q38962889 | Role of Protein Kinase G and Reactive Oxygen Species in the Regulation of Podocyte Function in Health and Disease |
| Q93148944 | Role of p53 Family Proteins in Metformin Anti-Cancer Activities |
| Q35612438 | Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects of metformin |
| Q37575477 | Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2. |
| Q28546852 | The 5'-AMP-Activated Protein Kinase (AMPK) Is Involved in the Augmentation of Antioxidant Defenses in Cryopreserved Chicken Sperm |
| Q37184638 | The Role of Metformin in Controlling Oxidative Stress in Muscle of Diabetic Rats |
| Q37951800 | The podocyte as a target for therapies--new and old. |
| Q34699773 | The podocyte power-plant disaster and its contribution to glomerulopathy |
| Q61814333 | Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes |
| Q35450699 | Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease |
Search more.